Robert J. Howard

6th Floor Maple House, 149 Tottenham Court Rd, W1T 7NF
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 246 publications

Blood-Based Biomarkers for Alzheimer Disease in Primary Care: The Gap Between Biology and Clinical Utility.

Blood-Based Biomarkers for Alzheimer Disease in Primary Care: The Gap Between Biology and Clinical Utility.

Journal: Neurology

Published: August 12, 2026

Retention, retention, retention for psychiatry's workforce.

Retention, retention, retention for psychiatry's workforce.

Journal: The British journal of psychiatry : the journal of mental science

Published: August 10, 2026

Authors' response to the letter.

Authors' response to the letter.

Journal: International psychogeriatrics

Published: July 26, 2026

Why is depression divisive in dementia prevention?

Why is depression divisive in dementia prevention?

Journal: Lancet (London, England)

Published: July 22, 2026

Cutting through stigma: psychiatry and neurosurgery working together.

Cutting through stigma: psychiatry and neurosurgery working together.

Journal: The British journal of psychiatry : the journal of mental science

Published: June 29, 2026

Response to Interpreting "intermittent" psychological distress in dementia research: A classification that obscures more than it reveals.

Response to Interpreting "intermittent" psychological distress in dementia research: A classification that obscures more than it reveals.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: June 09, 2026

Definition of treatment-resistant late-life depression: Conclusions from a European task force Delphi process.

Definition of treatment-resistant late-life depression: Conclusions from a European task force Delphi process.

Journal: European psychiatry : the journal of the Association of European Psychiatrists

Published: June 02, 2026

Definition of treatment-resistant late-life depression: Conclusions from a European Task Force Delphi process.

Definition of treatment-resistant late-life depression: Conclusions from a European Task Force Delphi process.

Journal: European psychiatry : the journal of the Association of European Psychiatrists

Published: June 02, 2026

What Does a Positive Alzheimer Disease Blood-Based Biomarker Result Mean in People With Mild Cognitive Impairment?

What Does a Positive Alzheimer Disease Blood-Based Biomarker Result Mean in People With Mild Cognitive Impairment?

Journal: Neurology

Published: May 04, 2026

Response to Kellner, Espinoza, Gligorovic, and Sartorius.

Response to Kellner, Espinoza, Gligorovic, and Sartorius.

Journal: Psychological medicine

Published: March 24, 2026

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 18, 2026

Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE4 heterozygotes and non-carriers.

Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE4 heterozygotes and non-carriers.

Journal: The journal of prevention of Alzheimer's disease

Published: March 06, 2026

Showing 1-12 of 246

Last Updated: 09/26/2026